Asymptomatic microscopic hematuria (AMH) is often incidental and innocuous; however, blood in the urine can be a sign of an underlying malignancy. The 2012 American Urological Association (AUA) guidelines for the evaluation of AMH advised all patients over the age of 35 to be evaluated with CT urography and cystoscopy, despite the incidence and mortality from urological cancer being significantly lower in women. Recently, American Urogynecologic Society (AUGS) and American College of Obstetricians and Gynecologists (ACOG) released a Committee Opinion1 advocating for strategic, gender specific screening. We therefore sought to perform a cost effectiveness analysis to quantify the cost savings of the decreased number of imaging tests and radiation with the gender specific protocol.

Sonia Dutta, MD [University of California, Irvine]

Coauthors
Southern California Permanente Medical Group: N M Guaderrama
Kaiser Permanente Southern California: E Whitcomb